Total Payments
$11,103
2024 Payments
$3,906
Companies
72
Transactions
505
Medicare Patients
27
Medicare Billing
$1,623
Payment Breakdown by Category
Food & Beverage$10,537 (94.9%)
Education$566.18 (5.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,537 | 497 | 94.9% |
| Education | $566.18 | 8 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $887.67 | 41 | $0 (2024) |
| Amgen Inc. | $642.21 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $620.38 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $603.93 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $557.93 | 23 | $0 (2024) |
| Incyte Corporation | $421.24 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $409.62 | 21 | $0 (2024) |
| Eisai Inc. | $358.51 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $319.10 | 11 | $0 (2024) |
| Blueprint Medicines Corporation | $318.95 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,906 | 165 | E.R. Squibb & Sons, L.L.C. ($395.12) |
| 2023 | $3,208 | 143 | E.R. Squibb & Sons, L.L.C. ($290.17) |
| 2022 | $1,919 | 96 | GENZYME CORPORATION ($140.82) |
| 2021 | $2,070 | 101 | Amgen Inc. ($300.30) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Oncology | ||||||
| 12/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: Hematology/Oncology | ||||||
| 12/23/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $24.51 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Genetically Defined Disease | ||||||
| 12/18/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 12/11/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.39 | General |
| 12/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Monoclonal Antibody | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $111.41 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Oncology | ||||||
| 11/19/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 13 | $1,365 | $654.28 |
| 2021 | 1 | 16 | 16 | $1,680 | $968.32 |
Total Patients
27
Total Services
29
Medicare Billing
$1,623
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $1,365 | $654.28 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 16 | $1,680 | $968.32 | 57.6% |
About Melissa Wills
Melissa Wills is a Primary Care healthcare provider based in Canfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1841789849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Wills has received a total of $11,103 in payments from pharmaceutical and medical device companies, with $3,906 received in 2024. These payments were reported across 505 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($10,537).
As a Medicare-enrolled provider, Wills has provided services to 27 Medicare beneficiaries, totaling 29 services with total Medicare billing of $1,623. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Family
- Location Canfield, OH
- Active Since 05/04/2018
- Last Updated 04/30/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841789849
Products in Payments
- OPDIVO (Biological) $964.27
- KEYTRUDA (Biological) $540.07
- IMBRUVICA (Drug) $423.98
- Lenvima (Drug) $342.09
- AYVAKIT (Drug) $318.95
- LIBTAYO (Biological) $311.16
- Nplate (Biological) $227.90
- VERZENIO (Drug) $200.98
- PROVENGE (Drug) $189.82
- LUMAKRAS (Drug) $179.39
- JAKAFI (Drug) $171.55
- Xtandi (Drug) $168.12
- KISQALI (Drug) $154.93
- REBLOZYL (Biological) $149.23
- Elahere (Biological) $130.11
- Enhertu (Drug) $129.59
- DARZALEX (Biological) $115.06
- INLYTA (Drug) $114.01
- ERLEADA (Drug) $113.62
- MONJUVI (Drug) $113.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.